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Abstract 
BACKGROUND: Although the prevalence of cardiovascular disease decreases in the general population, this 
pattern is not followed in hemodialysis patients. Hence cardiovascular events still occur in 50% of cases resulting 
in hemodialysis patients. One of the risk factors is vascular calcification. The pathogenesis is not yet fully 
understood, but recent years studies have shown that vascular calcification in chronic kidney disease (CKD) 
occurs as a result of the interaction of stimulatory and inhibitory factors. One of the inhibitory factors is Fetuin-A. 
Until now there has been no data on levels of Fetuin-A as a risk factor for abdominal aortic calcification in 
Indonesia.  
AIM: To determine the effect of Fetuin-A levels on abdominal aortic calcification in regular hemodialysis patients. 
METHODS: This study was a cross-sectional study on 76 regular hemodialysis patients at Rasyida Renal 
Hospital Medan. Fetuin-A level was examined by enzyme-linked immunosorbent assay (ELISA). Assessment of 
abdominal aortic calcification was done by lateral lumbar X-ray. 
RESULTS: Most patients (68.4%) had abdominal aortic calcification, in both layers; intima and media (44.7%). 
Abdominal aortic calcification was associated with Fetuin-A level and age. Multivariate analysis showed that high 
Fetuin-A levels were significantly associated with abdominal aortic calcification. 
CONCLUSION: High Fetuin-A level appeared to be a protective factor against abdominal aortic calcification in 
regular hemodialysis patients in Indonesia. 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
The life expectancy of hemodialysis patients 
is still very low. According to the United State Renal 
Data System in 2010, the 5-year cumulative life 
expectancy for chronic hemodialysis patients in North 
America is around 25% compared to 2005 which was 
only 20% [1]. Muzasti in 2011 found that the 5 years 
of survival rate for regular hemodialysis patients in 
Medan, Indonesia, was only 37.8% [2]. A study by 
Sibarani et al., in Medan, Indonesia, showed that the 
1-year survival rate of maintenance hemodialysis 
patients was 63.4% [3]. One of the main causes of 
this low survival in various countries is cardiovascular 
disease. Despite the declining prevalence in the 
general population, this pattern is not followed in 
hemodialysis patients. Hence cardiovascular events 
still occur in 50% of cases of mortality in hemodialysis 
patients [1]. 
One risk factor for high mortality from 
cardiovascular disease in hemodialysis patients is 
vascular calcification. The pathogenesis is very 
complex and not fully understood [4]. However, 
research in recent years has shown that vascular 
calcification in CKD occurs as a result of the 
interaction of stimulatory and inhibitory factors. One of 
the inhibitory factors is Fetuin-A. Research in dialysis 
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patients shows that the lower the level of Fetuin-A, the 
more extensive the vascular calcification that occurs 
[5]. The role of Fetuin-A in physiology is still under 
study. However, several reports have shown that 
Fetuin-A is a multifunctional protein that can work as a 
major vascular calcification inhibitor by inhibiting 50% 
calcium phosphate salts formation [6]. Until now in 
Indonesia, there are no data regarding the levels of 
Fetuin-A as a risk factor for vascular calcification in 
hemodialysis patients.  
Therefore, this study was conducted to 
determine the association of Fetuin-A levels and 
abdominal aortic calcification in regular hemodialysis 
patients. 
 
 
Methods 
 
Study design 
This study was a cross-sectional study on 76 
regular HD patients conducted in April 2018 at 
Rasyida Renal Hospital Medan. Each medical record 
was reviewed to verify the diagnosis and to obtain all 
relevant demographic and clinical data. Inclusion 
criteria were outpatients with age ≥ 18 years, on 
hemodialysis for ≥ 36 months independently of 
aetiology, and willing to undergo a lateral examination 
with lumbar X-ray and were taken a blood sample for 
laboratory examination. Patients who refused to 
continue the research and with lack of medical 
records were excluded. 
 
Assessments  
Lateral lumbar X-rays interpretation was 
performed by a radiologist who did not know the 
patient's clinical condition. Grading of calcification was 
assessed using abdominal aortic calcification scores 
where the scores in the abdominal aortic segment 
both the anterior and posterior walls in front of the one 
to fourth lumbar vertebrae (L1-L4) were summed up. 
Patients were told to have no calcification if the score 
was 0, mild calcification if the score was 1-4, severe 
calcification if the score was above 4 [7]. Blood 
samples were taken 5-10 minutes before the 
hemodialysis procedure. Then the levels of Fetuin-A 
serum were examined by ELISA technique. 
 
Statistical analysis  
All data were analysed with statistical SPSS 
22.0 software using univariate, bivariate and 
multivariate analysis. To assess numerical data 
distribution, the Kolmogorov-Smirnov test was used. 
Categorical and numerical variables were analysed 
using an independent T-test or Mann Whitney U test, 
and two categorical variables were analysed using the 
Chi-Square test or physic test. The multivariate 
analysis used logistic regression. A p-value < 0.05 is 
considered significant. 
 
 
Results 
 
From the 76 respondents, 47 patients (61.8%) 
were male, while the rest 29 (38.2%) were female. 
Patients aged between 25-78 years (mean 54.39 ± 
11.32 years) with a mean BMI of 24.16 ± 4.49 kg/m
2
 
(range 16.73 to 42.67). Most patients underwent 
hemodialysis for 10 hours a week (71.1%) and have 
undergone hemodialysis for 73.24 ± 35.11 months. 
The medical history showed that almost all 
patients had hypertension (75%). Only 14 patients 
(18.4%) had diabetes. A history of cardiovascular 
disease was known in only 15.8% of patients. Twenty-
four patients (31.6%) reported previously or currently 
smoking. 
On laboratory examination, the median (mean 
± SD) levels of calcium, phosphate, calcium 
phosphate product and Fetuin-A were 9.80 (9.74 ± 
0.73) mg/dL, 5.5 (5.47 ± 0.61) mg/dL, 52.91 (53.54 ± 
8.59) mg
2
/dL
2
 and 235 (254.08 ± 112.50) pg/ml. 
Examination of lateral lumbar images showed 
that vascular calcification was found in 52 patients 
(68.4%) with an average abdominal aortic calcification 
score of 6.67 ± 6.34. The highest incidence for 
calcification was found in both layers both intima and 
media (44.7%) followed by tunica media in only 
(15.8%), whereas the calcification of the tunica intima 
was found in 2 patients (2.6%). Based on the grading, 
it was found that the majority of respondents 
experienced severe vascular calcification (52.6%). 
Clinical characteristics of these study participants are 
presented in (Table 1). 
Table 1: Demographic and clinical characteristics of the study 
participants 
Variables n (%), median (min-max), mean ± SD 
Gender: Male vs female 47 (61.8%) vs 29 (38.2%) 
Age (years): 
≤ 60 vs > 60 
57 (25-78), 54.39 ± 11.32 
50 (65.7%) vs 26 (34.2%) 
BMI (kg/m
2
) 
< 23 vs ≥ 
23.37 (16.73 – 42.67), 24.16 ± 4.49 
34 (44.7%) vs 42 (55.3%) 
Dialysis duration (months): 
≤ 60 vs > 60 
67 (36-231), 73.24 ± 35.11 
35 (46.1%) vs 41 (53.9%) 
Dialysis hours per week: 10 vs 12 54 (71.1%) vs 22 (28.9%) 
Renal failure etiology:  
diabetic vs hipertension 
 
14 (18.4%) vs 57 (75%) 
History of cardiovascular disease: yes  12 (15.8%) 
Tobacco-smokers: yes 24 (31.6%) 
Abdominal aorta calcification scores 6 (0-19), 6.67 ± 6.34 
The degree of vascular calcification: 
None vs mild vs severe 
 
24 (31.6%) vs 12 (15.8%) vs 40 (52.6%) 
Location of calcification: 
Intima vs media vs intima + media 
 
2 (2.6%) vs 12 (15.8%) vs 34 (44.7%) 
Calcium  9.80 (8 – 11), 9.74 ± 0.73 
Phospate 5.5 (4.1 – 6.8), 5.47 ± 0.61 
CaxP 52.91 (33.60 – 69.36), 53.54 ± 8.59 
Fetuin-A 235 (78 – 756), 254.08 ± 112.50 
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To determine the relationship of various 
factors with abdominal aortic calcification, bivariate 
analysis was performed. Table 2 shows that, even 
though statistically not significant, male sex, higher 
BMI and longer dialysis vintage were associated with 
more vascular calcification. Patients who suffer from 
diabetes, hypertension, are smoking and have a 
history of the cardiovascular disease also, had more 
vascular calcifications than non-DM patients, 
normotensive patients, non-smokers and those with 
no history of cardiovascular disease, although the 
statistical differences were not significant (p > 0.05). 
The same appeared for higher calcium and phosphate 
levels; it was more likely to experience vascular 
calcification than lower calcium levels and phosphate 
levels. 
Table 2: Association of demographic and clinical 
characteristics with vascular calcification 
Variables Calcification (+) Calcification (-) p 
Gender; male  66% 34% 0.556 
Age:  59.04 ± 9.68 52.25 ± 11.46 0.014* 
BMI: 24.73 ± 4.99 22.94 ± 2.87 0.053 
Diabetes: yes 71.4% 28.6% 0.789 
Hypertension: yes 68.4% 31.6% 1.000 
History of cardiovascular disease: 
yes 
91.7% 8.3% 0.059 
Tobacco-smokers: yes 75.0% 25.0% 0.402 
Dialysis duration:  83.96 ± 42.47 68.29 ± 30.34 0.070 
Calcium  9.85 ± 0.61 9.70 ± 0.78 0.366 
Phospate 5.55 ± 0.61 5.44 ± 0.61 0.478 
CaxP 54.72 ±7.82 53.0 ± 8.95 0.422 
Fetuin-A 205.48 ± 41.81 359.38 ± 143.12 < 0.001* 
 
The results of the statistical analysis in table 2 
showed that the only significant variables for vascular 
calcifications were Fetuin-A levels (p < 0.001) and age 
(p = 0.014).  
To determine the correlation and strength 
between Fetuin-A levels and abdominal aortic 
calcification scores, a correlation test was conducted. 
The Kruskal Wallis test in Figure 1 showed that there 
was a significant negative correlation between Fetuin-
A levels and abdominal aortic calcification score (p < 
0.001), meaning that the lower the level of Fetuin-A, 
the higher the abdominal aortic calcification score. 
The value of r = -0.60 indicates that the strength of the 
correlation between the two variables is moderate. 
 
Figure 1: Serum Fetuin-A levels correlated negatively with 
abdominal aortic calcification score 
Figure 2 shows that there is a significant 
negative correlation between the levels of Fetuin-A 
and the degree of calcification (p < 0.001), where the 
more severe the calcification, the lower the level of 
Fetuin-A. 
 
Figure 2: Serum Fetuin-A levels based on abdominal aortic 
calcification severity 
 
To determine the most predominant variables 
associated with significant abdominal aortic 
calcification, a multivariate analysis was performed, 
including age, BMI, history of cardiovascular disease, 
dialysis vintage, and Fetuin-A levels 
Statistical analysis showed that Fetuin-A 
levels were protective, and older age and higher BMI 
were risk factors for developing abdominal aortic 
calcification.  
Table 3: Multivariate logistic regression analysis 
Variable OR 95% CI P 
Fetuin-A 0.98 0.96 – 0.99 0.001 
History of cardiovascular disease: 
yes 
6.13 0.97 – 38.92 0.054 
Age 4.44 1.12 – 17.68 0.034 
BMI 1.28 1.05 – 1.57 0.014 
 
 
 
Discussion 
 
Aetiology of CKD in Indonesia is different from 
other countries. In the United States, diabetes is the 
leading cause of CKD with a proportion reaching 37% 
followed by hypertension (24%), and the rest by other 
diseases. While in Indonesia, the main cause of CKD 
based on Indonesian Renal Registry (IRR) data is 
hypertension (44%), followed by diabetes (22%) and 
other diseases. The results of this study are 
consistent with the IRR data. The high rate of 
hypertension in this study is likely because patients 
P<0.00
1 
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are late referrals, where secondary hypertension has 
occurred due to kidney failure, so it is difficult to 
recognise whether hypertension occurs as a cause or 
as a result of CKD [8], [9]. Limitation of this study is 
that there is no biopsy done in patients to determine 
the aetiology of CKD, only by history taking of 
hypertension and consumed anti-hypertension drugs. 
In contrast to developed countries, all patients 
received dialysis services 3 times a week (4 
hours/session), but in this study, most patients 
received dialysis services only twice a week (5 
hours/session). This is because hemodialysis facilities 
in Indonesia are strongly influenced by the financing 
system, namely using national health insurance 
(JKN), which is generally done twice a week [8], [9]. 
This study proves that the prevalence of 
vascular calcification in chronic hemodialysis patients 
is quite high, i.e. 68% with a median (range) 
abdominal aortic calcification score of 5 (0-19). 
Publication in recent years shows that the prevalence 
of vascular calcification varies greatly from 60-100%, 
depending on the location of the examination and the 
diagnostic method used and in the area where the 
study was conducted [10]. London et al. reported 68% 
of 202 hemodialysis patients in France had arterial 
calcification determined by radiography and 
echocardiography [11]. An Australian study of 137 
hemodialysis patients found that the prevalence of 
abdominal aortic vascular calcification was 90% [12] 
while international multicenter reports from America, 
Canada, Puerto Rico, Spain, and the United Kingdom 
showed that with the radiographic method, the 
prevalence of abdominal aortic calcification was 
77.8% and with echocardiography, all patients (100%) 
had calcifications in the aortic and mitral valves [13]. 
Variation in this prevalence of vascular 
calcification is strongly influenced by the 
characteristics of the sample study. When the results 
of this study were compared with the results of 
previous studies, all of them found that older age was 
associated with vascular calcification [7], [14]. Reaven 
and Sack's study of 245 participants using EBCT 
found that patients over 61 years experienced severe 
aortic calcification [15]. This study also shows the 
same thing, that is the older the patient, the more 
severe the degree of vascular calcification. This is 
because the process of atherosclerosis has started 
since childhood, and continues to form atheroma with 
various lesions that form calcification. So, age is 
considered to be an important determinant of the 
presence of calcification [15]. 
Several studies have shown that abdominal 
aortic calcification is more common in patients 
undergoing long-term dialysis. For example, the 
Goldsmith et al., the study of 38 patients who 
underwent hemodialysis for 10-25 years, had 
radiographically increased the prevalence of vascular 
calcification from 39% at the start of dialysis to 92% 
after 16 years of dialysis with an average onset of 9.7 
years after starting dialysis [16]. Kawaguchi et al. 
found that the average duration of dialysis in patients 
with grade 1 aortic abdominal calcification was 41 
months, while patients with grade 3 calcification, had 
been on dialysis for 68 months [15]. 
This study shows that Fetuin-A levels are 
associated with vascular calcification, where the 
higher the level of Fetuin-A, the lower the degree of 
vascular calcification. These results are supported by 
previous studies which proved that low levels of 
Fetuin-A in hemodialysis patients were independently 
associated with the extent of vascular calcification 
[17]. 
Several limitations of our study should be 
emphasized. First, our study population is a single 
centre with a lower prevalence of diabetes, so it has 
not described the condition of all hemodialysis 
patients in Indonesia. Second, our study method is 
cross-sectional and observational, so that it cannot 
describe the causal relationship between various 
variables with vascular calcification and thirdly; fetuin-
A levels were measured once at the inclusion. 
Even so, for the best of our knowledge from 
the current body of evidence, this study was the first 
study in Indonesia to prove that high levels of Fetuin-A 
are a protective factor against vascular calcification. 
Further research is needed to extend the role of 
Fetuin-A in preventing the occurrence of vascular 
calcification. 
In conclusion, high serum fetuin-A levels are 
shown to be protective factors and are associated with 
low severity of abdominal aortic calcifications in 
regular hemodialysis patients in Indonesia. 
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